Piper Sandler is acting as sole manager for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INO:
- Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
- Inovio’s Earnings Call: INO-3107 Drives 2026 Focus
- Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
- Inovio reports Q4 EPS (26c), consensus (34c)
- Options Volatility and Implied Earnings Moves Today, March 12, 2026